Point72 Middle East Fze Amgen Inc Call Options Transaction History

Point72 Middle East Fze

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $7.34 Million - $8.28 Million	-28,700 Reduced 84.41%	5,300 $1.53 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $2.43 Million - $3.01 Million	11,100 Added 48.47%	34,000 $9.14 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $1.52 Million - $1.8 Million	7,100 Added 44.94%	22,900 $5.08 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $3.43 Million - $4.18 Million	-15,200 Reduced 49.03%	15,800 $3.82 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $7.1 Million - $9.02 Million	31,000 New	31,000 $0

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $148B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

Stay updated on Point72 Middle East Fze with notifications on news.